Best Agrolife Limited has informed the Exchange about Transcript
BESTAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Best Agrolife reported Q1 FY26 revenue of Rs. 382 crores, down 27% YoY from Rs. 519 crores, as the company deliberately shifted from a push to a pull-based sales model, deferring placements closer to the season. Despite the revenue dip, gross margins improved sharply to 30% from 24% YoY, EBITDA margin expanded 140 bps to 12%, and PAT remained stable at Rs. 20 crores with margin improving to 5% from 4%. Patented portfolio grew 14% YoY and now contributes 45% of brand sales. Sales returns dropped to Rs. 13 crores from Rs. 35-40 crores, with a Rs. 50 crore provision kept conservatively. Management guided FY26-27 revenue of Rs. 1,600-1,700 crores and annual EBITDA margin of 15%+, with OPEX expected to reduce by Rs. 30-40 crores YoY. A Rs. 90 crore CAPEX project at Gajraula is set to begin, with benefits flowing in FY27. Two new patents were granted, and international expansion continues across Africa, Sri Lanka, Australia, and South America.
Short-term, the stock may face pressure as top-line de-growth and a 25%+ revenue decline may concern investors, even though margins and profitability metrics have improved. Medium-term, the strategic shift toward patented products, lower sales returns, and tighter inventory/OPEX control should support more predictable earnings and a potential re-rating, contingent on management delivering on the FY27 margin and growth trajectory.